Search

everythinglearnresearchcommunity

for

Search:↓

Research 10 of 1000+

1. Widespread Dystrophic-Anagen Alopecia and Drug Eruption due to Usage of PEG-IFN ?-2a /Ribavirin Combination Therapy Hair therapy & transplantation · 2014 · 1 citations
2. Bullous Lesions at Polyethylene Glycol Interferon-alpha-2a Inoculation Site in a Hepatitis C Virus-infected Subject Acta Dermato Venereologica · 2007 · 2 citations
3. Reversible alopecia universalis secondary to PEG-interferon ??-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection European Journal of Gastroenterology & Hepatology · 2007 · 41 citations
4. Dystrophic-Anagen Effluvium Occurring During Pegylated Interferon-α-2a/Ribavirin Therapy Hepatitis Monthly · 2015 · 2 citations
5. Reversible Alopecia Universalis During Treatment with PEG-Interferon and Ribavirin for Chronic Hepatitis C Journal of Chemotherapy · 2005 · 27 citations
6. Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report Annals of Hepatology · 2014 · 3 citations
7. Lichen planus and other cutaneous manifestations in chronic hepatitis C: pre- and post-interferon-based treatment prevalence vary in a cohort of patients from low hepatitis C virus endemic area Journal of the European Academy of Dermatology and Venereology · 2008 · 34 citations
8. Comparison of viral RNA–host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2 Cell Research · 2021 · 100 citations
9. Pegylated-interferon-α_2ain clinical practice: how to manage patients suffering from side effects Expert Opinion on Drug Safety · 2011 · 17 citations
10. Sustained Exosome‐Guided Macrophage Polarization Using Hydrolytically Degradable PEG Hydrogels for Cutaneous Wound Healing: Identification of Key Proteins and MiRNAs, and Sustained Release Formulation Small · 2022 · 40 citations

Community

— no results